RecruitingNot ApplicableNCT06047353

Community Health Advocates for Motivating PAP Use in Our Neighborhoods.

Sponsor

University of Miami

Enrollment

48 participants

Start Date

Sep 29, 2023

Study Type

INTERVENTIONAL

Conditions

Obstructive Sleep Apnea

Summary

The purpose of this research is to compare the impact of motivational enhancement therapy (MET), delivered by culturally congruent community health care workers (CHWs) versus usual care patients with previously untreated moderate-to-severe obstructive sleep apnea (OSA) on adherence to positive airway pressure (PAP) therapy.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Motivational Enhancement Therapy and a medical device called Positive Airway Pressure (PAP) therapy for people with obstructive sleep apnea. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMotivational Enhancement Therapy

Motivational Enhancement Therapy (MET) is based on the principles of motivational interviewing and is designed to promote self-efficacy and maximize behavioral change. MET will be given via phone and/or in person (approximately 30 minutes) at baseline, week 1, week 2, week 4, and week 8.

DEVICEPositive Airway Pressure (PAP) therapy

Positive Airway Pressure (PAP) therapy will be administered as per standard of care.

Locations(1)

University of Miami

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06047353

Related Trials

Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation

NCT0744437227 locations

Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study

NCT048144203 locations

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

NCT0722676554 locations

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

NCT0722568660 locations

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

NCT041799811 location